ArticleNPJ breast cancer2025

HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy.

S Pizzamiglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.